Recombinant probiotic therapy in experimental colitis in mice

Folia Biologica (Czech Republic)

Volumn 58, Issue 6, 2012, Pages 238-245

  Gardlik, Roman ^a   Palffy, R ^a   Celec, P ^a,b  

^a Bratislava   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

Colitis; IL 10; Inflammatory bowel disease; Oxidative stress; Probiotic therapy

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBONYL DERIVATIVE; DEXTRAN SULFATE; INTERLEUKIN 10; PROBIOTIC AGENT; RECOMBINANT PROBIOTIC BACTERIA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BODY WEIGHT; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; ESCHERICHIA COLI; FEEDING; INFLAMMATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; WEIGHT REDUCTION;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOCOCCUS; MUS;

EID: 84879833579     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ahmed, F. E. (2003) Genetically modified probiotics in foods. Trends Biotechnol. 21, 491-497.
2. Benzie, I. F., Strain, J. J. (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239, 70-76.
3. Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., De Simone, C., Sartor, R. B. (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100, 1539-1546. (Pubitemid 41032360)
4. Blackburn, A. C., Doe, W. F., Buffinton, G. D. (1999) Protein carbonyl formation on mucosal proteins in vitro and in dextran sulfate-induced colitis. Free Radic. Biol. Med. 27, 262-270. (Pubitemid 29395417)
5. Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J. P., van Deventer, S. J., Neirynck, S., Peppelenbosch, M. P., Steidler, L. (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 4, 754-759. (Pubitemid 43841860)
6. Cukrowska, B., Lodinová-Žádníkova, R., Enders, C., Sonnenborn, U., Schulze, J., Tlaskalová-Hogenová, H. (2002) Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand. J. Immunol. 55, 204-209. (Pubitemid 34304560)
7. D'Inca, R., Barollo, M., Scarpa, M., Grillo, A. R., Brun, P., Vettorato, M. G., Castagliuolo, I., Sturniolo, G. C. (2011) Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig. Dis. Sci. 56, 1178-1187.
8. de Vrese, M., Schrezenmeir, J. (2008) Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111, 1-66.
9. Erel, O. (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem. 37, 277-285.
10. Foligne, B., Dessein, R., Marceau, M., Poiret, S., Chamaillard, M., Pot, B., Simonet, M., Daniel, C. (2007) Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 133, 862-874. (Pubitemid 47374132)
11. Food and Agriculture Organization of the United Nations, WHO (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. In: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. (http://www.who.int/ foodsafety/publications/fs-management/en/probiotics.pdf)
12. Fujimori, S., Tatsuguchi, A., Gudis, K., Kishida, T., Mitsui, K., Ehara, A., Kobayashi, T., Sekita, Y., Seo, T., Sakamoto, C. (2007) High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J. Gastroenterol. Hepatol. 22, 1199-120.
13. Geier, M. S., Butler, R. N., Giffard, P. M., Howarth, G. S. (2007) Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. Int. J. Food Microbiol. 114, 267-274. (Pubitemid 46283086)
14. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., Raupach, B., Sonnenborn, U., Eckert, J., Schumann, R. R., Wiedenmann, B., Dignass, A. U., Sturm, A. (2006) Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect. Immun. 74, 4075-4082. (Pubitemid 43993340)
15. Henker, J., Laass, M., Blokhin, B. M., Bolbot, Y. K., Maydannik, V. G., Elze, M., Wolff, C., Schulze, J. (2007) The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur. J. Pediatr. 166, 311-318. (Pubitemid 46295098)
16. Hickson, M., D'Souza, A. L., Muthu, N., Rogers, T. R., Want, S., Rajkumar, C., Bulpitt, C. J. (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335, 80.
17. Huibregtse, I. L., Snoeck, V., de Creus, A., Braat, H., De Jong, E. C., Van Deventer, S. J., Rottiers, P. (2007) Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133, 517-528. (Pubitemid 47187339)
18. Huynh, H. Q., deBruyn, J., Guan, L., Diaz, H., Li, M., Girgis, S., Turner, J., Fedorak, R., Madsen, K. (2009) Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm. Bowel Dis. 15, 760-768.
19. Imaoka, A., Shima, T., Kato, K., Mizuno, S., Uehara, T., Matsumoto, S., Setoyama, H., Hara, T., Umesaki, Y. (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J. Gastroenterol. 14, 2511-2516. (Pubitemid 352037738)
20. Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., De Simone, C., Madsen, K. (2004) DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126, 1358-1373. (Pubitemid 38552800)
21. Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., Wolff, C., Schulze, J. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617-1623. (Pubitemid 39434105)
22. Loessner, H., Leschner, S., Endmann, A., Westphal, K., Wolf, K., Kochruebe, K., Miloud, T., Altenbuchner, J., Weiss, S. (2009) Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect. 11, 1097-1105.
23. Lorea Baroja, M., Kirjavainen, P. V., Hekmat, S., Reid, G. (2007) Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 149, 470-479. (Pubitemid 47256152)
24. Lowry, O. H., Rosebrough, N. J., Fair, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J Biol. Chem. 193, 265-275.
25. Matthes, H., Krummenerl, T., Giensch, M., Wolff, C., Schulze, J. (2010) Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement. Altern. Med. 10, 13.
26. Negre-Salvayre, A., Coatrieux, C., Ingueneau, C., Salvayre, R. (2008) Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 153, 6-20.
27. Remer, K. A., Bartrow, M., Roeger, B., Moll, H., Sonnenborn, U., Oelschlaeger, T. A. (2009) Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88. Int. J. Med. Microbiol. 299, 467-478.
28. Rumi, G., Tsubouchi, R., Okayama, M., Kato, S., Mozsik, G., Takeuchi, K. (2004) Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig. Dis. Sci. 49, 1466-1472. (Pubitemid 39273624)
29. Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., Fellermann, K. (2007) Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75, 2399-2407. (Pubitemid 46744330)
30. Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., Remaut, E. (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352-1355. (Pubitemid 30656052)
31. Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., Remaut, E. (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21, 785-789. (Pubitemid 36791397)
32. Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., Modeo, M. E., Rodino', S., D'Amico, S., Sebkova, L., Sacca', N., Di Giulio, E., Luyya, F., Imeneo, M., Larussa, T., Di Rosa, S., Annese, V., Danese, S., Gasbarrini, A. (2010) Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol. 105, 2218-2227.
33. Ulisse, S., Gionchetti, P., D'Alo, S., Russo, F. P., Pesce, I., Ricci, G., Rizzello, F., Helwig, U., Cifone, M. G., Campieri, M., De Simone, C. (2001) Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol. 96, 2691-2699.
34. Waeytens, A., Ferdinande, L., Neirynck, S., Rottiers, P., De Vos, M., Steidler, L., Cuvelier, C. A. (2008) Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice. Inflamm. Bowel Dis. 14, 471-479. (Pubitemid 351571826)
35. Westendorf, A. M., Gunzer, F., Deppenmeier, S., Tapadar, D., Hunger, J. K., Schmidt, M. A., Buer, J., Bruder, D. (2005) Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules. FEMS Immunol. Med. Microbiol. 43, 373-384. (Pubitemid 40228949)
36. Wildt, S., Nordgaard, I., Hansen, U., Brockmann, E., Rumessen, J. J. (2011) A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. J. Crohn's Colitis 5, 115-121.
37. Woodcock, D. M., Crowther, P. J., Doherty, J., Jefferson, S., DeCruz, E., Noyer-Weidner, M., Smith, S. S., Michael, M. Z., Graham, M. W. (1989) Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res. 17, 3469-3478. (Pubitemid 19120446)